Strides Pharma Science Stock Screener | Share Price & Fundamental Analysis
STAR
Pharmaceuticals
Screen Strides Pharma Science share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹950.65
▲
49.90 (5.54%)
Share Price BSE
₹950.75
▲
49.70 (5.52%)
Market Cap
₹8,400.16 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
3.02
EPS (TTM)
₹390.55
Dividend Yield
0.44%
Debt to Equity
0.94
52W High
₹984.80
52W Low
₹570.60
Operating Margin
18.00%
Profit Margin
10.58%
Revenue (TTM)
₹1,248.00
EBITDA
₹249.00
Net Income
₹132.00
Total Assets
₹6,049.00
Total Equity
₹2,587.00
Strides Pharma Science Share Price History - Stock Screener Chart
Screen STAR historical share price movements with interactive charts. Analyze price trends and patterns.
Strides Pharma Science Company Profile - Fundamental Screener
Screen Strides Pharma Science company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for STAR shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE939A01011
Strides Pharma Science Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen STAR balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 6,049 | 5,840 | 6,638 | 6,976 | 7,015 | 6,152 | 7,980 | 6,708 | 8,105 | 7,659 |
| Current Assets | 3,099 | 2,969 | 3,243 | 3,362 | 2,817 | 2,372 | 3,049 | 2,484 | 3,792 | 3,595 |
| Fixed Assets | 1,899 | 1,865 | 2,311 | 2,347 | 2,219 | 2,099 | 3,648 | 2,977 | 2,980 | 2,499 |
| Liabilities | ||||||||||
| Total Liabilities | 6,049 | 5,840 | 6,638 | 6,976 | 7,015 | 6,152 | 7,980 | 6,708 | 8,105 | 7,659 |
| Current Liabilities | 871 | 889 | 1,475 | 1,181 | 1,463 | 1,012 | 2,516 | 2,191 | 2,119 | 2,813 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 2,587 | 2,072 | 2,173 | 2,383 | 2,814 | 2,595 | 2,802 | 2,618 | 2,882 | 2,906 |
| Share Capital | 92 | 92 | 90 | 90 | 90 | 90 | 90 | 90 | 89 | 89 |
| Reserves & Surplus | 2,460 | 2,034 | 2,105 | 2,269 | 2,687 | 2,438 | 2,559 | 2,374 | 2,659 | 2,774 |
Screen STAR income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept | 2022-Jun | 2022-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,248 | 1,128 | 1,206 | 1,160 | 1,195 | 4,354 | 1,030 | 1,075 | 1,035 | 939 | 1,014 | 933 | 954 | 954 | 952 |
| Expenses | 999 | 910 | 1,000 | 946 | 987 | 866 | 888 | 886 | 1,054 | 802 | 879 | 892 | 844 | 1,002 | 944 |
| EBITDA | 249 | 218 | 206 | 215 | 209 | 3,488 | 142 | 189 | -18 | 136 | 135 | 41 | 110 | -49 | 8 |
| Operating Profit % | 18.00% | 19.00% | 16.00% | 18.00% | 15.00% | 18.00% | 15.00% | 12.00% | -5.00% | 14.00% | 11.00% | -3.00% | 6.00% | -7.00% | -9.00% |
| Depreciation | 50 | 49 | 49 | 48 | 49 | 47 | 48 | 49 | 60 | 60 | 61 | 60 | 62 | 60 | 61 |
| Interest | 46 | 48 | 50 | 52 | 74 | 73 | 71 | 70 | 79 | 76 | 81 | 58 | 68 | 55 | 50 |
| Profit Before Tax | 153 | 122 | 106 | 114 | 86 | 3,369 | 23 | 70 | -157 | 0 | -7 | -78 | -20 | -163 | -103 |
| Tax | 22 | 17 | 21 | 24 | 14 | 19 | 13 | 16 | -7 | 10 | 7 | 4 | -38 | -28 | -132 |
| Net Profit | 132 | 106 | 86 | 90 | 72 | 3,350 | 10 | 54 | -150 | -9 | -14 | -82 | 19 | -135 | 29 |
| EPS | 13.84 | 10.81 | 8.92 | 9.56 | 7.81 | 364.64 | 1.98 | 5.43 | -14.54 | -0.79 | -1.06 | -8.86 | 2.54 | -15.13 | 3.25 |
Strides Pharma Science Cash Flow Screener - Liquidity Fundamentals
Screen STAR cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 684 | 701 | 44 | -258 | 481 | 205 | 60 | 187 | 288 | 73 |
| Investing Activities | -90 | -150 | 302 | -119 | -522 | 1,321 | -145 | 570 | -1,222 | -2,205 |
| Financing Activities | -643 | -693 | -214 | 421 | -16 | -1,709 | 194 | -1,016 | 338 | 2,944 |
| Net Cash Flow | -49 | -143 | 133 | 45 | -56 | -184 | 110 | -259 | -596 | 812 |
Screen STAR shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 27.86% | 28.30% | 28.30% | 26.82% | 25.84% | 25.86% | 25.88% | 27.39% |
| FII Holding | 28.51% | 28.02% | 28.32% | 28.48% | 30.08% | 26.71% | 24.57% | 0.00% |
| DII Holding | 12.98% | 13.30% | 13.72% | 16.92% | 18.24% | 18.56% | 18.04% | 17.56% |
| Govt Holding | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Public Holding | 22.44% | 22.10% | 21.52% | 20.86% | 18.57% | 20.87% | 21.19% | 22.65% |
| Other Holding | 8.20% | 8.27% | 8.14% | 6.90% | 7.26% | 8.00% | 10.32% | 32.39% |
| Shareholder Count | 91,206 | 92,889 | 95,125 | 114,236 | 96,009 | 91,917 | 84,695 | 91,182 |
Strides Pharma Science Dividend Screener - Share Yield Analysis
Screen STAR dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹4.00 | 0.44% |
| 2024-March | ₹2.50 | 0.37% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹14.00 | 1.66% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹4.50 | 0.69% |
Strides Pharma Science Index Membership - Market Screener Classification
Screen STAR by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Strides Pharma Science Market Events Screener - Corporate Actions
Screen STAR market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Extraordinary General Meeting | NA | 17.24% | ||
| Annual General Meeting | NA | 2.34% | ||
| Dividend | ₹ 2.50 /share | 60.70% | ||
| 2025-10-31 | 2025-10-31 | Quarterly Result Announcement | NA | 3.90% |
| 2025-08-07 | 2025-08-07 | Annual General Meeting | NA | -6.92% |
| 2025-07-29 | 2025-07-29 | Quarterly Result Announcement | NA | 5.08% |
| 2025-07-22 | 2025-07-22 | Dividend | ₹ 4.00 /share | 28.02% |
| 2025-05-22 | 2025-05-22 | Quarterly Result Announcement | NA | 4.76% |
| 2025-01-30 | 2025-01-30 | Quarterly Result Announcement | NA | -3.10% |
| 2024-10-24 | 2024-10-24 | Quarterly Result Announcement | NA | -5.05% |
| 2023-08-28 | 2023-08-28 | Annual General Meeting | NA | -0.09% |
| 2023-08-04 | 2023-08-04 | Dividend | ₹ 1.50 /share | 17.50% |
| 2021-08-05 | 2021-08-06 | Dividend | ₹ 2.50 /share | -3.83% |
| 2018-07-18 | 2018-07-18 | Change Of Name | NA | 0.00% |
Strides Pharma Science Competitors Screener - Peer Comparison
Screen STAR competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 412,950 | 39.35 | 54,729 | 9.71% | 10,980 | 39.47 |
| Divis Laboratories | 168,413 | 68.31 | 9,712 | 18.67% | 2,191 | 44.14 |
| Torrent Pharmaceuticals | 130,247 | 60.76 | 11,539 | 6.99% | 1,911 | 62.90 |
| Cipla | 121,238 | 22.46 | 28,410 | 7.12% | 5,291 | 46.90 |
| Dr Reddys Laboratories | 104,613 | 18.49 | 33,741 | 16.73% | 5,725 | 43.77 |
| Lupin | 96,056 | 22.19 | 22,910 | 13.74% | 3,306 | 55.44 |
| Zydus Life Science | 92,075 | 18.30 | 23,511 | 18.55% | 4,615 | 44.07 |
| Mankind Pharma | 89,356 | 51.11 | 12,744 | 20.90% | 2,007 | 44.20 |
| Aurobindo Pharma | 69,290 | 20.05 | 32,346 | 9.43% | 3,484 | 49.09 |
| Alkem Laboratories | 65,324 | 27.31 | 13,458 | 3.70% | 2,216 | 38.49 |
Strides Pharma Science Company Announcements - News Screener
Screen STAR latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-12-29 | Completion Of US-FDA Inspection At The Formulations Facility Of Strides Pharma Inc. USA A Step-Down Wholly Owned Subsidiary Of The Company | View |
| 2025-12-27 | Closure of Trading Window | View |
| 2025-12-03 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-11-17 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-05 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2025-11-01 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-10-31 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2025-10-31 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-10-31 | Outcome Of Board Meeting - Un-Audited Financial Results (Consolidated & Standalone) For The Quarter And Half Year Ended September 30 2025 | View |
| 2025-10-24 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-10-24 | Board Meeting Intimation for Intimation Regarding Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2025-10-17 | Strides And Incepta Partner To Expand WomenS Health Access With WHO-Prequalified Contraceptive | View |
| 2025-09-25 | Closure of Trading Window | View |
| 2025-09-24 | Strides Sustainability Report For FY25 | View |
| 2025-09-19 | 2Nd Reminder To Shareholders Whose Shares Are Due To Be Transferred To IEPF | View |
| 2025-09-17 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-09-08 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-08-26 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-08-25 | Deregistration Of A Non-Operating Step-Down Subsidiary Of The Company In South Africa | View |
| 2025-08-08 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |